SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-20-006939
Filing Date
2020-04-22
Accepted
2020-04-22 17:04:09
Documents
5
Effectiveness Date
2020-04-22

Document Format Files

Seq Description Document Type Size
1 defa14a.htm DEFA14A 31578
2 defa14a_001.jpg GRAPHIC 127878
3 defa14a_002.jpg GRAPHIC 167942
4 defa14a_003.jpg GRAPHIC 61261
5 defa14a_004.jpg GRAPHIC 67158
  Complete submission text file 0001493152-20-006939.txt   617191
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38738 | Film No.: 20808487
SIC: 2834 Pharmaceutical Preparations